BSX - Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems.
As of May 29, 2026: spot at $48.57, ATM IV 37.7%, max pain $60.00, net GEX $5.9M.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Market Cap
- $71.81B
- P/E Ratio
- 20.19
- Beta
- 0.62
- 52-Week Range
- 48.125-109.5
- CEO
- Michael F. Mahoney
- Employees
- 53,000
- IPO Date
- May 19, 1992
- Exchange
- NYSE
What BSX Looks Like to Options Traders Today
IV rank of 58.0% sits near the 1-year median, where strategy choice depends on directional conviction and the event calendar rather than vol regime alone; positive net gamma exposure ($5.9M) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.072) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The BSX overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked BSX overview questions
- What is BSX?
- BSX is the ticker symbol for Boston Scientific Corporation, a listed security. Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Listed on NYSE. BSX is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the BSX options snapshot look like today?
- As of May 29, 2026, the BSX options snapshot shows spot at $48.57, ATM IV 37.7%, IV rank 58.0%, max pain $60.00, net GEX $5.9M, expected move 10.80%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are BSX's key statistics?
- Boston Scientific Corporation (BSX) carries a market capitalization of $71.81B, trailing P/E ratio of 20.19, beta of 0.62 relative to the broader market, 52-week range of 48.125-109.5. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does BSX belong to?
- Boston Scientific Corporation operates in the Healthcare sector, in the Medical - Devices industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare BSX's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the BSX data on this page?
- The options snapshot above is dated May 29, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).